Skip to main content Back to Top

Pharmacogenomic Considerations for Mental Health Disorders

June 22, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Pharmacogenomics have started to become an increasingly important facet for the selection of therapies and treatment of mental health. In this episode, our content matter experts discuss pharmacogenomic testing, access, resources and education surrounding this evolving area of practice.


Seth BodineSeth Bodine is currently a doctor of pharmacy student with Idaho State University. He graduated cum laude from University of Alaska Anchorage in Fall 2021 with a BS in Natural Sciences.

Mary SpataforeMary Spatafore is a second year pharmacy student at Idaho State University College of Pharmacy. Mary plans on completing her PharmD as well as a masters in public health. Mary has an interest in public health and increasing access to healthcare for all.

Mary CutrightMary Cutright is from little Downey, ID population of 600. She is a Doctor of Pharmacy candidate for 2024 and looks forward to using pharmacogenomics in her future as a practicing pharmacist. The idea to individualize therapy is something that she didn't think was going to be possible in her life time. As this was a way for a mad scientist to make an apple purple and not actually use it to help individuals. The idea of helping patients by using their genetics to find the most efficacious treatment for them is straight out of a science fiction film. She is excited to be here with us.

Dalanie FisherDalanie Fisher is a third year pharmacy student who has always had a passion for connecting with others. She has found her true calling in pharmacy and looks forward to the rewarding work ahead.

Korawin TriyasakornKorawin Triyasakorn is a third-year pharmacy student and PharmD Candidate for 2024 at Idaho State University. Genetics and pharmacogenomics have always been a field of interest to her. She has received a pharmacogenomics certificate from the University of Pittsburgh and has been actively involved in pharmacogenomics projects at Idaho State University. Post-graduation, Korawin hopes to continue being involved in pharmacogenomics and pursue a fellowship.

Jennifer GarrettJennifer Garrett is an experienced ISU 2024 PharmD candidate, certified in Pharmacogenomics with a Bachelor of Science degree in both Biomedical Biology and Health Science. She works with multiple telepharmacies delivering health services and patient care to remote Idaho areas. Her future aim is to expand rural health access with more telepharmacy sites. Jennifer is actively involved in iDFY: Idaho Drug Free Youth Program and Medical Reserve Corps, offering mentorship, student support, and disaster response assistance.

Jared BarrottJared Barrott, PhD, is a cancer pharmacologist that specializes in personalized medicines for rare bone and muscle cancers. He teaches pharmacy students and graduate students principles of pharmacogenomics that apply across many disciplines. Dr. Barrott is a certified instructor in the Test2Learn Pharmacogenomics certificate program.

Renee RobinsonRenee Robinson, PharmD, MPH, MSPharm, MBA, is associate professor, Idaho State University College of Pharmacy and a former commissioned officer in the U.S. Public Health Service. She completed her PharmD at the University of Georgia, a residency at Nationwide Children’s Hospital, an NIH clinical research fellowship, and a pediatric pharmacotherapy fellowship at The Ohio State University. Her research has focused on addressing health disparities of underserved communities, working to establish health equity.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.